These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28881212)

  • 1. Nanofiltration as tertiary treatment method for removing trace pharmaceutically active compounds in wastewater from wastewater treatment plants.
    Garcia-Ivars J; Martella L; Massella M; Carbonell-Alcaina C; Alcaina-Miranda MI; Iborra-Clar MI
    Water Res; 2017 Nov; 125():360-373. PubMed ID: 28881212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of solute-solute interactions and cake enhanced concentration polarization during removal of pharmaceuticals from urban wastewater by nanofiltration.
    Azaïs A; Mendret J; Petit E; Brosillon S
    Water Res; 2016 Nov; 104():156-167. PubMed ID: 27522026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of pharmaceutically active compounds from water sources using nanofiltration and reverse osmosis membranes: Comparison of removal efficiencies and in-depth analysis of rejection mechanisms.
    Matin A; Jillani SMS; Baig U; Ihsanullah I; Alhooshani K
    J Environ Manage; 2023 Jul; 338():117682. PubMed ID: 37003228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of water matrix on the rejection of neutral pharmaceutically active compound by thin-film composite nanofiltration and reverse osmosis membranes.
    Shah IA; Ali S; Yang Z; Ihsanullah I; Huang H
    Chemosphere; 2022 Sep; 303(Pt 3):135211. PubMed ID: 35660049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of solution chemistry and polymeric natural organic matter on the removal of aquatic pharmaceutical residuals by nanofiltration.
    Zazouli MA; Susanto H; Nasseri S; Ulbricht M
    Water Res; 2009 Jul; 43(13):3270-80. PubMed ID: 19520413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of nanofiltration for the removal of carbamazepine, diclofenac and ibuprofen from drinking water sources.
    Vergili I
    J Environ Manage; 2013 Sep; 127():177-87. PubMed ID: 23708199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection of emerging organic micropollutants in nanofiltration-reverse osmosis membrane applications.
    Xu P; Drewes JE; Bellona C; Amy G; Kim TU; Adam M; Heberer T
    Water Environ Res; 2005; 77(1):40-8. PubMed ID: 15765934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of feed water pH and membrane material on nanofiltration of perfluorohexanoic acid in aqueous solution.
    Zeng C; Tanaka S; Suzuki Y; Fujii S
    Chemosphere; 2017 Sep; 183():599-604. PubMed ID: 28575703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of pharmaceutically-based N-nitrosodimethylamine precursors using nanofiltration.
    Woods GC; Sadmani AHMA; Andrews SA; Bagley DM; Andrews RC
    Water Res; 2016 Apr; 93():179-186. PubMed ID: 26905796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutically active compounds: Their removal during slow sand filtration and their impact on slow sand filtration bacterial removal.
    D'Alessio M; Yoneyama B; Kirs M; Kisand V; Ray C
    Sci Total Environ; 2015 Aug; 524-525():124-35. PubMed ID: 25889551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of pharmaceutical compounds in water and wastewater using fungal oxidoreductase enzymes.
    Naghdi M; Taheran M; Brar SK; Kermanshahi-Pour A; Verma M; Surampalli RY
    Environ Pollut; 2018 Mar; 234():190-213. PubMed ID: 29175684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of biofouling on the removal of pharmaceutically active compounds by a nanofiltration membrane.
    Yang Y; Li C; Hou LA
    Environ Sci Pollut Res Int; 2019 Oct; 26(30):30575-30583. PubMed ID: 29273979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
    Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
    Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of activated carbon preloading by EfOM fractions from treated wastewater on adsorption of pharmaceutically active compounds.
    Hu J; Shang R; Heijman B; Rietveld L
    Chemosphere; 2016 May; 150():49-56. PubMed ID: 26891356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of coagulation with ferric chloride as a pretreatment for fouling reduction during nanofiltration of rendering plant secondary effluent.
    Racar M; Dolar D; Špehar A; Kraš A; Košutić K
    Chemosphere; 2017 Aug; 181():485-491. PubMed ID: 28460295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pharmaceutical micropollutants on the membrane fouling of a submerged MBR treating municipal wastewater: case of continuous pollution by carbamazepine.
    Li C; Cabassud C; Reboul B; Guigui C
    Water Res; 2015 Feb; 69():183-194. PubMed ID: 25481077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of silica fouling on the removal of pharmaceuticals and personal care products by nanofiltration and reverse osmosis membranes.
    Lin YL; Chiou JH; Lee CH
    J Hazard Mater; 2014 Jul; 277():102-9. PubMed ID: 24560524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes.
    Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
    Water Res; 2009 May; 43(9):2349-62. PubMed ID: 19303127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.